Navigation Links
MRIGlobal, Evogen Announce Agreement In Development Of Diagnostic Solutions
Date:7/30/2013

KANSAS CITY, Mo., July 30, 2013 /PRNewswire-USNewswire/ -- MRIGlobal and Evogen Inc. today announced that they have agreed to a strategic collaboration to develop advanced molecular diagnostics products, targeted to support in vitro and clinical molecular diagnostics markets.

(Logo: http://photos.prnewswire.com/prnh/20130730/DC55501LOGO-a)

(Logo: http://photos.prnewswire.com/prnh/20130730/DC55501LOGO-b)

Evogen, based in Lenexa, Kansas, is a diagnostics company and developer and manufacturer of High Definition PCR (polymerase chain reaction) molecular diagnostics systems.

Under the new five-year agreement, MRIGlobal will provide product development services to Evogen, including assay development, technology transfer,  analytical and clinical studies, and commercialization support. Other terms of the agreement were not released.

Evogen was founded in 2002 as a spinout from MRIGlobal (then known as Midwest Research Institute). Evogen is also known for its air sampling and collection technology which is deployed in the U.S and abroad to collect air in critically sensitive situations.

"We envision a partnership built on an already strong foundation of our earlier work together," said Thomas M. Sack, Ph.D., MRIGlobal Interim President and Chief Executive Officer. "Evogen and MRIGlobal see opportunities to collaborate on delivering new and innovative solutions that can help physicians make earlier and more accurate diagnoses."

"We are very pleased to announce this partnership and look forward to expediting optimization of our molecular platform for use around the globe," said Hans Kastensmith, President and Chief Executive Officer of Evogen. "MRIGlobal is a strong partner for product research and development and together we will accelerate the delivery of advanced diagnostic products to help advance health care."

The non-exclusive agreement is effective immediately.

About Evogen, Inc.
Evogen meets the molecular diagnostic collection and detection needs of a diverse range of customers. The Evogen portfolio includes DNA extraction methodologies, air collection and monitoring and proprietary PCR probe technology providing reliable, sensitive and specific answers. Through analysis of the specific needs of each customer, Evogen delivers systems and solutions that provide rapid results while lessening laboratory workflow impact. Visit www.Evogen.com.

About MRIGlobal
MRIGlobal, a not-for-profit research and development organization, delivers solutions in global health, national security and defense, and energy and the environment. The organization performs scientific research, advanced engineering, integration, and program management for clients in government, industry, and academia. Established in 1944 as Midwest Research Institute, MRIGlobal is based in Kansas City, Mo., operates in nine states and Washington, D.C. MRIGlobal employs more than 500 and manages 2,600-plus workers through management and operations programs with government clients.

MRIGlobal's Diagnostics Division provides assay development for menu expansion in in vitro and molecular diagnostics, validation and clinical testing, sample access and reference material, and platform engineering and integration. MRIGlobal operates a Clinical Laboratory Improvement Amendments (CLIA)-laboratory accredited by the College of American Pathologists. MRIGlobal is ISO 9001 certified and employs current Good Manufacturing Practices and Good Laboratory Practices, and maintains Biosafety Level 3 laboratories.

For more information, visit www.mriglobal.org/diagnostics.


'/>"/>
SOURCE MRIGlobal
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. North South Holdings Inc. Announces its First Settlement and License Agreement.
2. Tisch MS Researchers Announce Breakthrough in Disease Monitoring
3. Naurex Announces Issuance Of New Patent For Novel Antidepressant GLYX-13
4. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
5. VirtualScopics Schedules Second Quarter 2013 Earnings Announcement
6. Endo to Announce Second Quarter 2013 Financial Results on August 6, 2013
7. BioDrain Announces Medical Advisory Board Comprised of Top Doctors and Healthcare Executive
8. NeuroSigma Announces FDA Approval to Commence Phase III Trial
9. Simcere Pharmaceutical Group to Announce Second Quarter 2013 Financial Results on Tuesday, August 13, 2013
10. The Galien Foundation Announces 2013 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"
11. IRIDEX Announces Second Quarter 2013 Conference Call and Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... LAS VEGAS , June 26, 2016 ... movement to value-based care operating models within the health ... that enable greater financial efficiency , Deloitte offers ... address the key business issues impacting efficient cost optimization: ... alignment , These services facilitate better outcomes and ...
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/26/2016)... N.J. (PRWEB) , ... June 27, 2016 , ... Quality ... sources, yet in many ways they remain in the eye of the beholder, according ... (EBO), a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to ... app. The fitness app plans to fix the two major problems leading the fitness industry ... fits all type program , They don’t eliminate all the reasons people quit ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):